Skip to content

PRA Group

US · PRAA #3451 by market cap
20.03 -0.29 -1.43%
Live - 5344 symbols - heartbeat 47s ago · 2026-10-09 19:30

Analyst consensus 1 analysts

Buy
Avg price target 26.00 +29.8%
Price target rangecurrent 20.03
Low26.00
Avg26.00
High26.00
Buy 100% Hold 0% Sell 0%
Recent ratings (5)
DateFirmAnalystRatingTarget
2026-08-07 Truist Financial -- BUY 26.00
2026-05-08 Truist Financial -- BUY 26.00
2026-02-27 Truist Financial -- BUY 26.00
2026-01-28 Citizens JMP -- HOLD --
2025-11-04 Truist Financial -- BUY 26.00

Quant vs Street three independent views, side by side

Momentum strategy signal
Buy
Analyst consensus
Buy

All 2 views agree: bullish.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-08-06 After close ±12.21% +9.04% (in line)
2026/Q1 2026-05-07 After close ±9.22% -8.14% (in line)
2025/Q4 2026-02-26 After close ±17.76% +24.31% (beat)
2025/Q3 2025-11-03 After close ±12.12% -10.99% (in line)
2025/Q2 2025-08-04 After close ±15.68% -0.45% (in line)
2025/Q1 2025-05-05 After close ±12.20% -29.32% (beat)
2024/Q4 2025-02-19 After close ±11.61% -4.18% (in line)
2024/Q3 2024-11-04 After close ±12.16% +15.90% (beat)
2024/Q2 2024-08-05 After close ±14.01% -8.86% (in line)
2024/Q1 2024-05-06 After close ±10.68% -1.14% (in line)
2023/Q4 2024-02-15 After close ±15.37% +14.24% (in line)
2023/Q3 2023-11-06 After close ±15.36% +16.64% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.

PRA Group discussion 0 comments

Add a comment